ArticleCureus2026
Ipsilateral Double Parathyroid Adenomas Causing Primary Hyperparathyroidism: A Rare Case.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Double parathyroid adenomas represent an uncommon but well-recognized subset of primary hyperparathyroidism. Awareness of this possibility is essential, as failure to identify multigland involvement preoperatively may result in intraoperative uncertainty, incomplete resection, and persistent disease. Despite advances in localization techniques, the sensitivity of commonly used imaging modalities - including ultrasonography, technetium-99m sestamibi scintigraphy, and four-dimensional computed tomography - remains limited in detecting double adenomas. We present the case of a patient with primary hyperparathyroidism, who had two left-sided parathyroid adenomas identified on preoperative imaging and confirmed intraoperatively. This report aims to highlight ipsilateral double adenoma disease as a rare but clinically significant entity. In addition, we review adjunctive preoperative risk stratification models and intraoperative biochemical monitoring strategies that may improve recognition of multigland disease and reduce the need for extensive bilateral neck exploration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.